Sims Karen 4
4 · Arbutus Biopharma Corp · Filed Jul 12, 2023
Insider Transaction Report
Form 4
Sims Karen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-10+153,640→ 153,640 totalExercise: $2.26Exp: 2033-07-10→ Common Shares (153,640 underlying)
Footnotes (1)
- [F1]This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.